McKesson Ventures
  • Portfolio
  • News
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us

Latent Raises $80M to Close the Gap Between Diagnosis and Treatment

by Megan Durham | Mar 19, 2026 | Press Releases

Clinical-AI innovation company Latent recently announced the completion of a $80M Series A funding round, led by Spark Capital and Transformation Capital, along with participation from Conviction, McKesson Ventures, General Catalyst, and Y Combinator. This new capital...

McKesson Ventures Joins Series C Round for Evariant

by Megan Durham | May 10, 2016 | Portfolio News

McKesson Ventures, the healthcare services and information technology arm of McKesson Corp., has made an investment in Evariant, a Farmington, Connecticut-based company that provides customer-relationship management technology to hospitals and health systems. This...

McKesson Ventures Joins Series C Round for Evariant

by Megan Durham | May 10, 2016 | Press Releases

Recent Posts

  • BranchLab Raises $26M Series A Led by McKesson Ventures to Bring AI to Pharma Commercialization
  • Atropos Health CEO Brigham Hyde Discusses Healthcare and Medical Technology Trends With McKesson Ventures Partner Michelle Snyder on Breaking Health Podcast
  • Latent Raises $80M to Close the Gap Between Diagnosis and Treatment
  • Midi Health Surpasses $1B Valuation, Igniting a New Era for Women’s Health
  • Oath Surgical Announces AI-Native Surgical Centers Powered by NVIDIA
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104

IN THE NEWS

ABOUT US

CONTACT US

  • Follow
©2026 McKesson Ventures | Privacy Notice | Disclaimer | Cookie Settings
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104

©2026 McKesson Ventures | Privacy Notice | Disclaimer | Cookie Settings